Concepts (158)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Digital Rectal Examination | 1 | 2014 | 42 | 0.490 |
Why?
|
| Radiosurgery | 4 | 2019 | 1329 | 0.490 |
Why?
|
| Radiotherapy, Conformal | 2 | 2014 | 548 | 0.420 |
Why?
|
| Hyperparathyroidism, Primary | 1 | 2012 | 160 | 0.370 |
Why?
|
| HSP90 Heat-Shock Proteins | 2 | 2009 | 434 | 0.330 |
Why?
|
| Cranial Irradiation | 2 | 2020 | 401 | 0.290 |
Why?
|
| Adenoma | 2 | 2014 | 2174 | 0.270 |
Why?
|
| Lymphoma, B-Cell | 1 | 2012 | 931 | 0.270 |
Why?
|
| Pituitary Neoplasms | 1 | 2014 | 1345 | 0.250 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2012 | 1101 | 0.250 |
Why?
|
| Prostate-Specific Antigen | 1 | 2014 | 2494 | 0.240 |
Why?
|
| Disease Management | 1 | 2014 | 2459 | 0.220 |
Why?
|
| Skin Neoplasms | 3 | 2019 | 5686 | 0.190 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2008 | 2455 | 0.170 |
Why?
|
| Benzoquinones | 2 | 2009 | 201 | 0.160 |
Why?
|
| Lactams, Macrocyclic | 2 | 2009 | 320 | 0.150 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 1 | 2018 | 180 | 0.140 |
Why?
|
| Breast Neoplasms | 4 | 2014 | 20822 | 0.130 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2009 | 5535 | 0.130 |
Why?
|
| Severity of Illness Index | 1 | 2012 | 15540 | 0.120 |
Why?
|
| Cisplatin | 1 | 2021 | 1662 | 0.120 |
Why?
|
| Endometrial Neoplasms | 2 | 2014 | 1353 | 0.120 |
Why?
|
| Radiotherapy Dosage | 3 | 2019 | 2879 | 0.120 |
Why?
|
| Tumor Burden | 3 | 2018 | 1915 | 0.120 |
Why?
|
| Immunocompromised Host | 1 | 2019 | 847 | 0.110 |
Why?
|
| Cysts | 1 | 2019 | 678 | 0.110 |
Why?
|
| Brain Neoplasms | 3 | 2019 | 8863 | 0.110 |
Why?
|
| Mastectomy, Segmental | 2 | 2021 | 956 | 0.110 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 2020 | 1624 | 0.100 |
Why?
|
| Prostatic Neoplasms | 1 | 2014 | 11124 | 0.100 |
Why?
|
| Parathyroid Neoplasms | 1 | 2012 | 245 | 0.100 |
Why?
|
| Drug Therapy | 1 | 2014 | 497 | 0.100 |
Why?
|
| Parathyroidectomy | 1 | 2012 | 235 | 0.090 |
Why?
|
| Photons | 1 | 2014 | 588 | 0.090 |
Why?
|
| Muscle Weakness | 1 | 2012 | 413 | 0.090 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2014 | 713 | 0.090 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2019 | 9239 | 0.080 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 1 | 2008 | 146 | 0.080 |
Why?
|
| Receptors, Growth Factor | 1 | 2009 | 334 | 0.080 |
Why?
|
| Kidney Calculi | 1 | 2012 | 465 | 0.080 |
Why?
|
| Receptor, erbB-3 | 1 | 2008 | 142 | 0.080 |
Why?
|
| Neurosurgical Procedures | 1 | 2018 | 2002 | 0.080 |
Why?
|
| Serum | 1 | 2008 | 214 | 0.070 |
Why?
|
| Cricetulus | 1 | 2008 | 816 | 0.070 |
Why?
|
| Abdominal Pain | 1 | 2012 | 1063 | 0.070 |
Why?
|
| Parathyroid Hormone | 1 | 2012 | 1801 | 0.070 |
Why?
|
| CHO Cells | 1 | 2008 | 1406 | 0.070 |
Why?
|
| Radiotherapy | 1 | 2012 | 1533 | 0.060 |
Why?
|
| Fatigue | 1 | 2012 | 1531 | 0.060 |
Why?
|
| Cricetinae | 1 | 2008 | 2472 | 0.060 |
Why?
|
| DNA Repair | 1 | 2014 | 2046 | 0.060 |
Why?
|
| Regression Analysis | 1 | 2014 | 6459 | 0.060 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 2938 | 0.060 |
Why?
|
| Enzyme Activation | 2 | 2008 | 3701 | 0.060 |
Why?
|
| Neoplasms, Second Primary | 1 | 2012 | 1061 | 0.060 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 5221 | 0.060 |
Why?
|
| Retrospective Studies | 7 | 2019 | 77449 | 0.060 |
Why?
|
| Neoplasm Staging | 2 | 2021 | 11031 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2009 | 2503 | 0.060 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2019 | 4034 | 0.060 |
Why?
|
| Follow-Up Studies | 4 | 2019 | 39050 | 0.050 |
Why?
|
| Middle Aged | 9 | 2021 | 213383 | 0.050 |
Why?
|
| Risk | 1 | 2014 | 9687 | 0.050 |
Why?
|
| Quinazolines | 1 | 2008 | 1356 | 0.050 |
Why?
|
| Salvage Therapy | 2 | 2018 | 1275 | 0.050 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2009 | 1660 | 0.050 |
Why?
|
| Aged | 6 | 2021 | 163280 | 0.050 |
Why?
|
| Humans | 19 | 2022 | 744343 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2014 | 8428 | 0.050 |
Why?
|
| Indoles | 1 | 2009 | 1839 | 0.050 |
Why?
|
| Recurrence | 1 | 2012 | 8340 | 0.050 |
Why?
|
| Skin | 1 | 2014 | 4364 | 0.050 |
Why?
|
| Genome, Human | 1 | 2013 | 4420 | 0.040 |
Why?
|
| Sulfonamides | 1 | 2009 | 1938 | 0.040 |
Why?
|
| Calcium | 1 | 2012 | 5756 | 0.040 |
Why?
|
| Female | 11 | 2021 | 380194 | 0.040 |
Why?
|
| Prospective Studies | 4 | 2021 | 53288 | 0.040 |
Why?
|
| Piperazines | 1 | 2009 | 2488 | 0.040 |
Why?
|
| Maximum Tolerated Dose | 1 | 2021 | 892 | 0.040 |
Why?
|
| Treatment Outcome | 5 | 2019 | 63114 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2001 | 648 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2022 | 13102 | 0.040 |
Why?
|
| Combined Modality Therapy | 2 | 2021 | 8642 | 0.040 |
Why?
|
| Feasibility Studies | 2 | 2020 | 5078 | 0.040 |
Why?
|
| Adult | 5 | 2021 | 214055 | 0.040 |
Why?
|
| Male | 7 | 2019 | 350118 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2009 | 4554 | 0.040 |
Why?
|
| Erythema | 1 | 2018 | 257 | 0.040 |
Why?
|
| Hyperpigmentation | 1 | 2018 | 112 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2014 | 16689 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2001 | 1285 | 0.030 |
Why?
|
| Apoptosis | 2 | 2009 | 9727 | 0.030 |
Why?
|
| Aged, 80 and over | 3 | 2019 | 57776 | 0.030 |
Why?
|
| Young Adult | 3 | 2021 | 56430 | 0.030 |
Why?
|
| Multivariate Analysis | 2 | 2019 | 12245 | 0.030 |
Why?
|
| Fat Necrosis | 1 | 2014 | 58 | 0.030 |
Why?
|
| Radiodermatitis | 1 | 2014 | 60 | 0.030 |
Why?
|
| Telangiectasis | 1 | 2014 | 76 | 0.030 |
Why?
|
| Necrosis | 1 | 2018 | 1643 | 0.030 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2019 | 1770 | 0.030 |
Why?
|
| Depression | 1 | 2012 | 7766 | 0.030 |
Why?
|
| Neoplasms | 2 | 2014 | 21683 | 0.030 |
Why?
|
| DNA Polymerase II | 1 | 2013 | 107 | 0.030 |
Why?
|
| Mastectomy | 1 | 2021 | 1793 | 0.030 |
Why?
|
| Skin Pigmentation | 1 | 2014 | 282 | 0.030 |
Why?
|
| Signal Transduction | 3 | 2013 | 23403 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2018 | 2618 | 0.030 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2001 | 1888 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2014 | 13695 | 0.020 |
Why?
|
| Radiation Injuries | 1 | 2018 | 1180 | 0.020 |
Why?
|
| Animals | 3 | 2014 | 168757 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2012 | 40561 | 0.020 |
Why?
|
| Genomic Instability | 1 | 2014 | 695 | 0.020 |
Why?
|
| Immunologic Factors | 1 | 2019 | 1580 | 0.020 |
Why?
|
| Artificial Intelligence | 1 | 2022 | 2214 | 0.020 |
Why?
|
| Protein Kinase C-delta | 1 | 2009 | 123 | 0.020 |
Why?
|
| Hippocampus | 1 | 2020 | 3675 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 6538 | 0.020 |
Why?
|
| DNA Replication | 1 | 2014 | 1399 | 0.020 |
Why?
|
| Hematologic Neoplasms | 1 | 2019 | 1832 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 2013 | 1813 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2014 | 1403 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2009 | 578 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 1 | 2009 | 873 | 0.020 |
Why?
|
| Gene Amplification | 1 | 2009 | 1063 | 0.020 |
Why?
|
| Child | 1 | 2012 | 77709 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2013 | 1941 | 0.020 |
Why?
|
| Adolescent | 1 | 2012 | 85781 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2013 | 4186 | 0.020 |
Why?
|
| Survival Rate | 1 | 2018 | 12788 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 12354 | 0.010 |
Why?
|
| Algorithms | 1 | 2022 | 13881 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 2014 | 3396 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2009 | 6314 | 0.010 |
Why?
|
| Threonine | 1 | 2001 | 279 | 0.010 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2001 | 337 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2001 | 697 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2001 | 1723 | 0.010 |
Why?
|
| Genomics | 1 | 2013 | 5720 | 0.010 |
Why?
|
| Tyrosine | 1 | 2001 | 1461 | 0.010 |
Why?
|
| Ovarian Neoplasms | 1 | 2013 | 4838 | 0.010 |
Why?
|
| Time Factors | 1 | 2018 | 40075 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2013 | 9648 | 0.010 |
Why?
|
| Point Mutation | 1 | 2001 | 1623 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2001 | 3129 | 0.010 |
Why?
|
| United States | 1 | 2022 | 69872 | 0.010 |
Why?
|
| Prognosis | 1 | 2014 | 29063 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2001 | 5179 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2013 | 12208 | 0.010 |
Why?
|
| HIV Infections | 1 | 2019 | 16718 | 0.010 |
Why?
|
| Brain | 1 | 2018 | 26385 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2001 | 2752 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2001 | 8436 | 0.010 |
Why?
|
| Base Sequence | 1 | 2001 | 12797 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2001 | 13815 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2001 | 18111 | 0.000 |
Why?
|
| Rats | 1 | 2001 | 24260 | 0.000 |
Why?
|
| Mice | 1 | 2001 | 81183 | 0.000 |
Why?
|
Concepts
(158)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(62)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_